Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K B Kim

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 9, 2008
In vitro metabolism of a novel PPAR gamma agonist, KR-62980, and its stereoisomer, KR-63198, in human liver microsomes and by recombinant cytochrome P450sK-B Kim, K-A Seo, Y-J Yoon, et al.
Archives of Pharmacal Research|January 6, 1999
Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5)S K Sohn, M S Chang, Y K Chung, et al.
Toxicology|April 20, 2000
Cadmium induces caspase-mediated cell death: suppression by Bcl-2M S Kim, B J Kim, H N Woo, et al.
Canadian Journal of Physiology and Pharmacology|March 5, 1999
The biochemical and pharmacological properties of a newly synthesized H+-K+ ATPase inhibitor, 2-dimethylamino-4,5-dihydrothiazolo[4,5:3,4]pyridol-[1,2-a]benzimidazol eY K Chung, M S Chang, K B Kim, et al.
Arzneimittel-Forschung|September 15, 2001
General pharmacological properties of YJA20379-8, a new H+/K(+)-ATPase inhibitor with anti-ulcer activitiesE B Lee, S I Cho, H O Chang, et al.
Scandinavian Journal of Rheumatology|April 15, 2020
Incidence, survival, and risk of cardiovascular events in adult inflammatory myopathies in South Korea: a nationwide population-based studyK H Jung, H J Kim, W Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic dosesK Schwarz, R de Giuli, G Schmidtke, et al.
Neuroscience Letters|December 4, 2003
Effective treatment with fucoidin for perinatal hypoxic-ischemic encephalopathy in ratsC-S Uhm, K-B Kim, J H Lim, et al.
Journal of Korean Medical Science|April 6, 2001
Transplacental transfer and age-related levels of serum IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae types 14 and 19 in KoreaJ K Yoon, H H Lee, B M Choi, et al.
Stroke|January 4, 2001
Intracranial cerebral artery disease as a risk factor for central nervous system complications of coronary artery bypass graft surgeryB W Yoon, H J Bae, D W Kang, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 9, 2008
In vitro metabolism of a novel PPAR gamma agonist, KR-62980, and its stereoisomer, KR-63198, in human liver microsomes and by recombinant cytochrome P450sK-B Kim, K-A Seo, Y-J Yoon, et al.
Archives of Pharmacal Research|January 6, 1999
Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5)S K Sohn, M S Chang, Y K Chung, et al.
Toxicology|April 20, 2000
Cadmium induces caspase-mediated cell death: suppression by Bcl-2M S Kim, B J Kim, H N Woo, et al.
Canadian Journal of Physiology and Pharmacology|March 5, 1999
The biochemical and pharmacological properties of a newly synthesized H+-K+ ATPase inhibitor, 2-dimethylamino-4,5-dihydrothiazolo[4,5:3,4]pyridol-[1,2-a]benzimidazol eY K Chung, M S Chang, K B Kim, et al.
Arzneimittel-Forschung|September 15, 2001
General pharmacological properties of YJA20379-8, a new H+/K(+)-ATPase inhibitor with anti-ulcer activitiesE B Lee, S I Cho, H O Chang, et al.
Scandinavian Journal of Rheumatology|April 15, 2020
Incidence, survival, and risk of cardiovascular events in adult inflammatory myopathies in South Korea: a nationwide population-based studyK H Jung, H J Kim, W Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic dosesK Schwarz, R de Giuli, G Schmidtke, et al.
Neuroscience Letters|December 4, 2003
Effective treatment with fucoidin for perinatal hypoxic-ischemic encephalopathy in ratsC-S Uhm, K-B Kim, J H Lim, et al.
Journal of Korean Medical Science|April 6, 2001
Transplacental transfer and age-related levels of serum IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae types 14 and 19 in KoreaJ K Yoon, H H Lee, B M Choi, et al.
Stroke|January 4, 2001
Intracranial cerebral artery disease as a risk factor for central nervous system complications of coronary artery bypass graft surgeryB W Yoon, H J Bae, D W Kang, et al.
Pageof 10